狠狠色丁香久久综合婷婷亚洲成人福利在线-欧美日韩在线观看免费-国产99久久久久久免费看-国产欧美在线一区二区三区-欧美精品一区二区三区免费观看-国内精品99亚洲免费高清

            您好, 歡迎來(lái)到化工儀器網(wǎng)

            | 注冊(cè)| 產(chǎn)品展廳| 收藏該商鋪

            15000105423

            news

            首頁(yè)   >>   公司動(dòng)態(tài)   >>   翻倍增長(zhǎng) | Absin 產(chǎn)品引用文獻(xiàn)已超4000篇

            愛(ài)必信(上海)生物科技有...

            立即詢(xún)價(jià)

            您提交后,專(zhuān)屬客服將第一時(shí)間為您服務(wù)

            翻倍增長(zhǎng) | Absin 產(chǎn)品引用文獻(xiàn)已超4000篇

            閱讀:1026      發(fā)布時(shí)間:2022-12-14
            分享:

            Absin,您身邊的科研百寶箱,作為高品質(zhì)生命科學(xué)產(chǎn)品的中國(guó)品牌、生物化學(xué)試劑專(zhuān)家,Absin產(chǎn)品涵蓋生化試劑、分子生物學(xué)、小分子化合物,細(xì)胞生物學(xué)、免疫學(xué)、耗材、產(chǎn)品定制和檢測(cè)服務(wù)等。
             

            越來(lái)越多使用我們產(chǎn)品的高分文獻(xiàn)發(fā)表!發(fā)表速度越來(lái)越快!
             

            截至目前,我們檢索發(fā)現(xiàn)、統(tǒng)計(jì)得到的Absin收錄的產(chǎn)品文獻(xiàn)數(shù)量已超4000篇!更多文獻(xiàn)在發(fā)表中,也歡迎老師們及時(shí)提報(bào)給我們您的文獻(xiàn)發(fā)表情況,領(lǐng)取您的文獻(xiàn)發(fā)表獎(jiǎng)勵(lì)哦!
             

            我們的爆款熱賣(mài)產(chǎn)品發(fā)表文獻(xiàn)數(shù)量也越來(lái)越多,全面優(yōu)質(zhì)的產(chǎn)品、總有一款適合您!
             

            2022年部分文獻(xiàn)展示:
             

            ? Suppression of PFKFB3-driven glycolysis restrains endothelial-to-mesenchymal transition and fibrotic response.(IF 38.104)
            ? Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1.(IF 38.104)
            ? Biomimetic Immunosuppressive Exosomes that Inhibit Cytokine Storms Contribute to the Alleviation of Sepsis.(IF 30.849)
            ? A minimally designed PD-L1-targeted nanocomposite for positive feedback-based multimodal cancer therapy. (IF 26.943)
            ? Anti-alcoholism drug disulfiram for targeting glioma energy metabolism using BBB-penetrating delivery of fixed-dose combination. (IF 20.722)
            ? A Mouse-adapted CVA6 Strain Exhibits Neurotropism and Triggers Systemic Manifestations in a Novel Murine Model. (IF 19.568)
            ? Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer. (IF 19.456)
            ? Manganese immunotherapy for treating osteosarcoma: Glycosylating 1V209 anchored MnO2 nanosheets prompt pro-inflammatory macrophage polarization. (IF 18.962)
            ? Reprogramming dysfunctional dendritic cells by a versatile metabolism nano-intervenor for enhancing cancer combinatorial immunotherapy. (IF 18.962)
            ? HAp Thermosensitive Nanohydrogel Cavities Act as Brood Pouches to Incubate and Control-Release NSCs for Rapid Spinal Cord Injury Therapy. (IF 18.808)
            ? Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments. (IF 17.694)
            ? Phosphorylation of Jhd2 by the Ras-cAMP-PKA(Tpk2) pathway regulates histone modifications and autophagy. (IF 17.694)
            ? A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma. (IF 17.694)
            ? Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK. (IF 17.694)
            ? Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer. (IF 16.988)
            ? Cytokine nanosponges suppressing overactive macrophages and dampening systematic cytokine storm for the treatment of hemophagocytic lymphohistiocytosis. (IF 16.874)
            ? Prussian Blue Nanoparticles Stabilize SOD1 from Ubiquitination-Proteasome Degradation to Rescue Intervertebral Disc Degeneration. (IF 16.806)
            ? Hypoxia-responsive immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy for potentiating cancer immunotherapy. (IF 16.744)
            ? Lymphocyte infiltration and thyrocyte destruction are driven by stromal and immune cell components in Hashimoto’s thyroiditis. (IF 14.919)
            ? The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes. (IF 14.919)
            ? Seamless and early gap healing of osteochondral defects by autologous mosaicplasty combined with bioactive supramolecular nanofiber-enabled gelatin methacryloyl (BSN-GelMA) hydrogel. (IF 14.593)
            ? Verteporfin-mediated on/off photoswitching functions synergistically to treat choroidal vascular diseases. (IF 14.593)
            ? Biomimetic manganese-based theranostic nanoplatform for cancer multimodal imaging and twofold immunotherapy. (IF 14.593)
            ? CD301b+ macrophages mediate angiogenesis of calcium phosphate bioceramics by CaN/NFATc1/VEGF axis. (IF 14.593)
            ? N6-methyladenosine plays a dual role in arsenic carcinogenesis by temporal-specific control of core target AKT1. (IF 14.224)
            ? Impact and microbial mechanism of continuous nanoplastics exposure on the urban wastewater treatment process. (IF 13.4)
            ? Acid-Responsive Aggregated Gold Nanoparticles for Radiosensitization and Synergistic Chemoradiotherapy in the Treatment of Esophageal Cancer. (IF 13.281)
            ? Targeting N7-Methylguanosine tRNA modification blocks hepatocellular carcinoma metastasis after insufficient radiofrequency ablation. (IF 12.91)
            ? Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin. (IF 12.658)
            ? CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ. (IF 12.658)
            ? Mitochondrial calpain-1 activates NLRP3 inflammasome by cleaving ATP5A1 and inducing mitochondrial ROS in CVB3-induced myocarditis. (IF 12.416)
            ? Clusterin negatively modulates mechanical stress-mediated ligamentum flavum hypertrophy through TGF-β1 signaling. (IF 12.153)
            ? Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction. (IF 11.799)
            ? Broad-spectrum and powerful neutralization of bacterial toxins by erythroliposomes with the help of macrophage uptake and degradation. (IF 11.614)
            ? All-stage targeted therapy for the brain metastasis from triple-negative breast cancer. (IF 11.614)
            ? Multi-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma. (IF 11.556)
            ? AdMSC-derived exosomes alleviate acute lung injury via transferring mitochondrial component to improve homeostasis of alveolar macrophages. (IF 11.556)
            ? CircRNA DDX21 acts as a prognostic factor and sponge of miR‐1264/QKI axis to weaken the progression of triple‐negative breast cancer. (IF 11.492)
            ? SlRBP1 promotes translational efficiency via SleIF4A2 to maintain chloroplast function in tomato. (IF 11.277)

             

            我們秉承踏實(shí), 務(wù)實(shí),求精和不斷創(chuàng)新的精神為中國(guó)科學(xué)家提供優(yōu)質(zhì)的產(chǎn)品,努力打造屬于中國(guó)自己的生物試劑品牌!客戶(hù)文章的集中發(fā)表是對(duì)我們最大的鼓勵(lì)和鞭策, 我們將以此為動(dòng)力,繼續(xù)埋頭苦干, 繼續(xù)為廣大科學(xué)家提供更全面更豐富更優(yōu)質(zhì)的產(chǎn)品。

             

            會(huì)員登錄

            請(qǐng)輸入賬號(hào)

            請(qǐng)輸入密碼

            =

            請(qǐng)輸驗(yàn)證碼

            收藏該商鋪

            標(biāo)簽:
            保存成功

            (空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)

            常用:

            提示

            您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~
            在線留言